MARKET

MYL

Mylan NL
MYL
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
487.85
0.7131
0.6532
8,586,209,642.01
BUZZ-Regeneron closes higher after favorable US court ruling in eye drug suit
Regeneron Pharmaceuticals closes 2.88% higher at $873.98. Shares hit record high of $899.86 during regular trading. West Virginia court ruled in favor of REGN in a patent suit for its eye drug Eylea, against Mylan.
Reuters · 12/27/2023 21:40
Viatris core profit beats on generic drugs strength
Viatris core profit beats on generic drugs strength. shares up about 2% in extended trading. viatris was formed through merger of mylan and pfizer's branded drugs business. company's revenue fell about 3% to $3.94 billion in the third quarter.
Reuters · 11/07/2023 23:21
BUZZ-Viatris falls as on president Malik's retirement plan
Reuters · 10/23/2023 11:38
US Patent Office won't review two Novo Nordisk patents for Wegovy, Ozempic
Reuters · 10/02/2023 20:51
BUZZ-Viatris to divest some businesses for $3.6 bln; shares up
Reuters · 10/02/2023 11:32
Viatris beats second-quarter revenue estimates, says divestiture plans on track
Reuters · 08/07/2023 12:23
Viatris defeats IRS appeal in clash over legal fees in patent cases
Reuters · 07/27/2023 16:39

Webull offers Mylan NL stock information, including NASDAQ: MYL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MYL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MYL stock methods without spending real money on the virtual paper trading platform.